5-fluorodopa has been researched along with Hyperplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alanen, K; Bergman, J; Gullichsen, R; Kauhanen, S; Minn, H; Nuutila, P; Parkkola, R; Salmi, J; Salonen, A; Sane, T; Seppänen, M; Solin, O; Välimäki, M | 1 |
1 other study(ies) available for 5-fluorodopa and Hyperplasia
Article | Year |
---|---|
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Insulin-Secreting Cells; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |